{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:57:55Z","timestamp":1787162275510,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["961662"],"award-info":[{"award-number":["961662"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["965391"],"award-info":[{"award-number":["965391"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1902C"],"award-info":[{"award-number":["01GM1902C"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cellsig.2021.110069","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T12:22:22Z","timestamp":1624969342000},"page":"110069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Rigosertib elicits potent anti-tumor responses in colorectal cancer by inhibiting Ras signaling pathway"],"prefix":"10.1016","volume":"85","author":[{"given":"Farzad","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Hashemzehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Barneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Asgharzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Moradi Marjaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atena","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Parizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ghayour Mobarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Ryzhikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohieddin","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal Carcinoma: a general overview and future perspectives in colorectal cancer","volume":"18","author":"Marmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1470-2045(15)70127-0","volume":"16","author":"Tabernero","year":"2015","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.cellsig.2021.110069_bb0015","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2004.11.037","article-title":"Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment","volume":"22","author":"Grothey","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1758834015591952","article-title":"Precision medicine in colorectal cancer: the molecular profile alters treatment strategies","volume":"7","author":"Tran","year":"2015","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.gendis.2014.10.002","article-title":"Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer","volume":"2","author":"Knickelbein","year":"2015","journal-title":"Genes & Diseases"},{"issue":"11","key":"10.1016\/j.cellsig.2021.110069_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2021.110069_bb0035","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: mission possible?","volume":"13","author":"Cox","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0040","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1158\/1078-0432.CCR-09-2446","article-title":"Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases","volume":"16","author":"Baldus","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1947601911408079","article-title":"RAS interaction with PI3K: more than just another effector pathway","volume":"2","author":"Castellano","year":"2011","journal-title":"Genes & cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cell.2016.03.045","article-title":"A small molecule RAS-mimetic disrupts RAS association with effector proteins to block signaling","volume":"165","author":"Athuluri-Divakar","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2014.02.018","article-title":"Combination PI3K\/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer","volume":"347","author":"Roper","year":"2014","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.cellsig.2021.110069_bb0060","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.cell.2015.05.033","article-title":"Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer","volume":"161","author":"Dow","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.leukres.2011.08.022","article-title":"Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910. Na","volume":"36","author":"Seetharam","year":"2012","journal-title":"Leukemia Res"},{"issue":"6","key":"10.1016\/j.cellsig.2021.110069_bb0070","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/1078-0432.CCR-13-2506","article-title":"Phase I study of oral rigosertib (ON 01910. Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies","volume":"20","author":"Bowles","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/cas.12605","article-title":"Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by DNA damage-induced G2\/M arrest","volume":"106","author":"Hyoda","year":"2015","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2021.110069_bb0080","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/leu.2013.79","article-title":"Phase I study of ON 01910. Na (Rigosertib), a multikinase PI3K inhibitor in relapsed\/refractory B-cell malignancies","volume":"27","author":"Roschewski","year":"2013","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.cellsig.2021.110069_bb0085","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1158\/1535-7163.MCT-13-0206","article-title":"The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas","volume":"12","author":"Anderson","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.cellsig.2021.110069_bb0090","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/1078-0432.CCR-11-2113","article-title":"ON 01910. Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K\/AKT inhibition and induction of oxidative stress","volume":"18","author":"Chapman","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2021.110069_bb0095","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/onc.2008.502","article-title":"Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells","volume":"28","author":"Prasad","year":"2009","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.cellsig.2021.110069_bb0100","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/1078-0432.CCR-11-2113","article-title":"ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K\/AKT inhibition and induction of oxidative stress","volume":"18","author":"Chapman","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2021.110069_bb0105","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1038\/srep07310","article-title":"Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome","volume":"4","author":"Xu","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2021.110069_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117470","article-title":"Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K\/AKT and NF-?B signaling pathways","author":"Rahmani","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.molcel.2016.10.029","article-title":"Inhibition of Ras\/Raf\/MEK\/ERK pathway signaling by a stress-induced phospho-regulatory circuit","volume":"64","author":"Ritt","year":"2016","journal-title":"Mol. Cell"},{"issue":"W1","key":"10.1016\/j.cellsig.2021.110069_bb0120","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-017-0691-y","article-title":"Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies","volume":"16","author":"Berg","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2021.110069_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.9","article-title":"DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information","volume":"5","author":"Amelio","year":"2014","journal-title":"Cell Death Dis."},{"issue":"15","key":"10.1016\/j.cellsig.2021.110069_bb0135","doi-asserted-by":"crossref","first-page":"19813","DOI":"10.18632\/oncotarget.7852","article-title":"Decreased level of RASSF6 in sporadic colorectal cancer and its anti-tumor effects both in vitro and in vivo","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0140","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3109\/10717544.2014.916768","article-title":"Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer","volume":"23","author":"Zhang","year":"2016","journal-title":"Drug Deliv"},{"issue":"30","key":"10.1016\/j.cellsig.2021.110069_bb0145","doi-asserted-by":"crossref","first-page":"48360","DOI":"10.18632\/oncotarget.10235","article-title":"PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.cellsig.2021.110069_bb0150","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1002\/jcp.26538","article-title":"Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer","volume":"233","author":"Marjaneh","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0155","doi-asserted-by":"crossref","first-page":"p. djt346","DOI":"10.1093\/jnci\/djt346","article-title":"Role of CYB5A in pancreatic cancer prognosis and autophagy modulation","volume":"106","author":"Giovannetti","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.cellsig.2021.110069_bb0160","doi-asserted-by":"crossref","first-page":"14123","DOI":"10.1002\/jcp.28104","article-title":"PNU-74654 enhances the antiproliferative effects of 5-FU in breast cancer and antagonizes thrombin-induced cell growth via the Wnt pathway","volume":"234","author":"Rahmani","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"20","key":"10.1016\/j.cellsig.2021.110069_bb0165","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2021.110069_bb0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-62703-239-1_8","article-title":"Colorimetric detection of senescence-associated beta galactosidase","volume":"965","author":"Itahana","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"39","key":"10.1016\/j.cellsig.2021.110069_bb0175","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.2174\/1381612825666190110145151","article-title":"Phytosomal curcumin elicits anti-tumor properties through suppression of angiogenesis, cell proliferation and induction of oxidative stress in colorectal cancer","volume":"24","author":"Moradi-Marjaneh","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.cellsig.2021.110069_bb0180","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1002\/jcb.26796","article-title":"Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer","volume":"119","author":"Hashemzehi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.cellsig.2021.110069_bb0185","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1002\/jcb.27367","article-title":"Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt\/PI3K pathway in a mouse model of colitis-associated colorectal cancer","volume":"119","author":"Amerizadeh","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.cellsig.2021.110069_bb0190","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1002\/jcb.26796","article-title":"Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer","volume":"119","author":"Hashemzehi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059772","article-title":"BRG1 is a prognostic marker and potential therapeutic target in human breast cancer","volume":"8","author":"Bai","year":"2013","journal-title":"PloS one"},{"issue":"8","key":"10.1016\/j.cellsig.2021.110069_bb0200","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1182\/blood-2014-10-609339","article-title":"Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation","volume":"125","author":"Dinarvand","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cellsig.2021.110069_bb0205","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jcp.24568","article-title":"Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells","volume":"229","author":"Hassanian","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jth.12899","article-title":"Inorganic polyphosphate elicits pro-inflammatory responses through activation of the mammalian target of rapamycin complexes 1 and 2 in vascular endothelial cells","volume":"13","author":"Hassanian","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.cellsig.2021.110069_bb0215","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jth.13477","article-title":"Inorganic polyphosphate promotes cyclin D1 synthesis through activation of mTOR\/Wnt\/beta-catenin signaling in endothelial cells","volume":"14","author":"Hassanian","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0220","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jamcollsurg.2009.12.008","article-title":"Novel expression patterns of PI3K\/Akt\/mTOR signaling pathway components in colorectal cancer","volume":"210","author":"Johnson","year":"2010","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110069_bb0225","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1158\/1078-0432.CCR-17-1234","article-title":"Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies","volume":"24","author":"Sveen","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ccr.2005.02.009","article-title":"ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent","volume":"7","author":"Gumireddy","year":"2005","journal-title":"Cancer Cell"},{"issue":"48","key":"10.1016\/j.cellsig.2021.110069_bb0235","doi-asserted-by":"crossref","first-page":"79388","DOI":"10.18632\/oncotarget.12692","article-title":"ON 01910.Na (rigosertib) inhibits PI3K\/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines","volume":"7","author":"Prasad","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2021.110069_bb0240","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1038\/ncomms11363","article-title":"Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cvr\/cvr002","article-title":"GSK-3beta at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways","volume":"90","author":"Vigneron","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2001-1326-3-23","article-title":"Biomechanics of TGF\u00df-induced epithelial-mesenchymal transition: implications for fibrosis and cancer","volume":"3","author":"O\u2019Connor","year":"2014","journal-title":"Clin Transl Med"},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0255","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1042\/BJ20111240","article-title":"Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression","volume":"441","author":"Shields","year":"2012","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0260","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cellsig.2021.110069_bb0265","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/onc.2015.162","article-title":"IFN? induces oxidative stress, DNA damage and tumor cell senescence via TGF\u00df\/SMAD signaling-dependent induction of Nox4 and suppression of ANT2","volume":"35","author":"Hubackova","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0270","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","article-title":"Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin","volume":"290","author":"Svastova","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"21","key":"10.1016\/j.cellsig.2021.110069_bb0275","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0280","first-page":"997","article-title":"Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation","volume":"34","author":"Liotta","year":"1974","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2021.110069_bb0285","article-title":"Therapeutic effects of silver nanoparticle containing sulfasalazine on DSS-induced colitis model","author":"Asgharzadeh","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0290","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1002\/jcp.29333","article-title":"Role of regulatory miRNAs of the PI3K\/AKT\/mTOR signaling in the pathogenesis of hepatocellular carcinoma","volume":"235","author":"Rahmani","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"39","key":"10.1016\/j.cellsig.2021.110069_bb0295","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.2174\/1381612825666190110151957","article-title":"Role of regulatory oncogenic or tumor suppressor miRNAs of PI3K\/AKT signaling axis in the pathogenesis of colorectal cancer","volume":"24","author":"Soleimani","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"23","key":"10.1016\/j.cellsig.2021.110069_bb0300","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1158\/1078-0432.CCR-09-1249","article-title":"Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer","volume":"15","author":"Gulhati","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1078-0432.CCR-14-3081","article-title":"Tankyrase inhibition blocks Wnt\/\u00df-catenin pathway and reverts resistance to PI3K and AKT inhibitors in the treatment of colorectal cancer","volume":"22","author":"Arqu\u00e9s","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0310","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jcp.25897","article-title":"Role of Wnt\/\u00df-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer","volume":"233","author":"Rahmani","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110069_bb0315","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.7314\/APJCP.2013.14.4.2201","article-title":"Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K\/Akt\/mTOR and Wnt Pathways","volume":"14","author":"Pandurangan","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093210","article-title":"Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in asian populations: insights from a meta-analysis","volume":"9","author":"Zhao","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0325","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mc.22498","article-title":"Metformin induces degradation of cyclin D1 via AMPK\/GSK3\u00df axis in ovarian cancer","volume":"56","author":"Gwak","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0330","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/13543784.2014.867017","article-title":"Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present","volume":"23","author":"Casimiro","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"12","key":"10.1016\/j.cellsig.2021.110069_bb0335","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/onc.2008.502","article-title":"Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells","volume":"28","author":"Prasad","year":"2009","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2021.110069_bb0340","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/0008-5472.CAN-12-1365","article-title":"Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism","volume":"73","author":"Rahmani","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/bb2f92ec-2ac1-4952-b744-0519aeb10d1c","article-title":"Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K\/Akt pathway in gliomas","volume":"9","author":"Malla","year":"2014","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0350","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/jid.2012.10","article-title":"MDM2 Inhibitor Nutlin-3a Induces Apoptosis and Senescence in Cutaneous T-Cell Lymphoma: Role of p53","volume":"132","author":"Manfe","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.cellsig.2021.110069_bb0355","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1385\/MB:32:3:227","article-title":"Control of the G(2)\/M transition","volume":"32","author":"Stark","year":"2006","journal-title":"Mol. Biotechnol."},{"issue":"12","key":"10.1016\/j.cellsig.2021.110069_bb0360","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1039\/c0pp00244e","article-title":"UVB-Induced p21 degradation promotes apoptosis of human keratinocytes","volume":"9","author":"Lei","year":"2010","journal-title":"Photochemical & Photobiological Sciences"},{"key":"10.1016\/j.cellsig.2021.110069_bb0365","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12659\/MSMBR.893608","article-title":"The role of p21 in apoptosis, proliferation, cell cycle arrest, and antioxidant activity in UVB-irradiated human HaCaT keratinocytes","volume":"21","author":"Chen","year":"2015","journal-title":"Med. Sci. Monit. Basic Res."},{"issue":"48","key":"10.1016\/j.cellsig.2021.110069_bb0370","doi-asserted-by":"crossref","first-page":"79388","DOI":"10.18632\/oncotarget.12692","article-title":"ON 01910. Na (rigosertib) inhibits PI3K\/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines","volume":"7","author":"Prasad","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0375","first-page":"4663","article-title":"MgCl2 and ZnCl2 promote human umbilical vein endothelial cell migration and invasion and stimulate epithelial-mesenchymal transition via the Wnt\/\u00df-catenin pathway","volume":"14","author":"Pan","year":"2017","journal-title":"Experimental and therapeutic medicine"},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0380","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3892\/ijo_00000761","article-title":"Involvement of the Wnt-\u00df-catenin pathway in invasion and migration of oral squamous carcinoma cells","volume":"37","author":"Iwai","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2021.110069_bb0385","article-title":"E-cadherin\/\u00df-catenin complex and the epithelial barrier","volume":"2011","author":"Tian","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110069_bb0390","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cell.2005.09.021","article-title":"a-catenin is a molecular switch that binds E-cadherin-\u00df-catenin and regulates actin-filament assembly","volume":"123","author":"Drees","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2021.110069_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22940-3","article-title":"Dual role of E-cadherin in the regulation of invasive collective migration of mammary carcinoma cells","volume":"8","author":"Elisha","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0400","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jcp.26012","article-title":"Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin","volume":"233","author":"Zhou","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"24","key":"10.1016\/j.cellsig.2021.110069_bb0405","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1038\/sj.onc.1208552","article-title":"Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis","volume":"24","author":"Klampfer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2021.110069_bb0410","series-title":"Drug Interactions in Infectious Diseases","first-page":"1","article-title":"Introduction to drug interactions","author":"Khaliq","year":"2001"},{"issue":"8","key":"10.1016\/j.cellsig.2021.110069_bb0415","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1631\/jzus.B1300303","article-title":"Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells","volume":"15","author":"Ng","year":"2014","journal-title":"Journal of Zhejiang University-SCIENCE B"},{"key":"10.1016\/j.cellsig.2021.110069_bb0420","series-title":"Pharmacogenetics: Making Cancer Treatment Safer and More Effective","article-title":"Clinical pharmacology and anticancer drugs","author":"Rodr\u00edguez-Antona","year":"2010"},{"issue":"4","key":"10.1016\/j.cellsig.2021.110069_bb0425","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","article-title":"Discordant protein and mRNA expression in lung adenocarcinomas","volume":"1","author":"Chen","year":"2002","journal-title":"Molecular & cellular proteomics"},{"issue":"2","key":"10.1016\/j.cellsig.2021.110069_bb0430","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbrc.2017.01.102","article-title":"Discordant mRNA and protein expression of CXCR4 under in vitro CoCl2-induced hypoxic conditions","volume":"484","author":"Tang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656821001583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656821001583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:44:56Z","timestamp":1784904296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656821001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":86,"alternative-id":["S0898656821001583"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2021.110069","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rigosertib elicits potent anti-tumor responses in colorectal cancer by inhibiting Ras signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2021.110069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110069"}}